483
Brian I Rini MDBrian I Rini MD – FDA 483, Jan 25, 2019
Record Details
An FDA inspection of Brian I Rini MD in Cleveland, OH, a clinical investigator site, revealed significant deficiencies in the reporting of adverse events and adherence to investigational plans. The firm failed to promptly report a serious adverse event to the sponsor and did not report numerous non-serious adverse events or concomitant medications as required by the study protocol. These findings indicate a serious lack of oversight in clinical trial conduct.
View Company Profile
ID · fca0e5f0-1a22-44de-ad05-64cfa06db194
Other documents for Brian I Rini MD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.